In support of this, patients with severe COVID-19 (5) exhibited higher IL-6/IFN-γ ratio and greater lunch damage while a higher risk of hypercytokinemic immune dysregulation (or cytokine syndrome), respiratory failure, and death (76) was characterized by elevated IL-6 levels ≥80 pg/mL. This evidence concerns the gene IL6 and COVID-19.